Estados Unidos · Bolsa y Finanzas · MarketWatch

Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

Publicado por MarketWatch · Estados Unidos hace 10 h

Alvotech shares rose after the company said the Food and Drug Administration has approved a supplement to the biologics license application for AVT02 adalimumab-ryvk, marketed in…

Leer el artículo completo en MarketWatch Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketwatch.com)

Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

También te puede interesar

Starbucks recovery plan is working. Here's how Mike Khouw says to trade the coffee giant

TikTok rolls out an AI shopping assistant and one-click checkout

Senator Moreno warns Anthropic CEO of 'catastrophic' approach to AI

The college with the highest first-year retention rate in every state

CNN C.E.O. Mark Thompson Says He Will Stay On Under New Owner Skydance

$9.6 Billion in Southeast Asian Upstream Assets Are for Sale Through 2027

Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

Compartir

También te puede interesar

Starbucks recovery plan is working. Here's how Mike Khouw says to trade the coffee giant

TikTok rolls out an AI shopping assistant and one-click checkout

Senator Moreno warns Anthropic CEO of 'catastrophic' approach to AI

The college with the highest first-year retention rate in every state

CNN C.E.O. Mark Thompson Says He Will Stay On Under New Owner Skydance

$9.6 Billion in Southeast Asian Upstream Assets Are for Sale Through 2027